- Home
- ITRG vs MRNS Comparison
ITRG vs MRNS Comparison
Compare ITRG & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- MRNS
- Stock Information
- Founded
- ITRG 1997
- MRNS 2003
- Country
- ITRG Canada
- MRNS United States
- Employees
- ITRG N/A
- MRNS N/A
- Industry
- ITRG Precious Metals
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- MRNS Health Care
- Exchange
- ITRG Nasdaq
- MRNS Nasdaq
- Market Cap
- ITRG 84.2M
- MRNS 104.7M
- IPO Year
- ITRG N/A
- MRNS 2014
- Fundamental
- Price
- ITRG $1.20
- MRNS $0.31
- Analyst Decision
- ITRG Strong Buy
- MRNS Buy
- Analyst Count
- ITRG 1
- MRNS 12
- Target Price
- ITRG $3.75
- MRNS $4.56
- AVG Volume (30 Days)
- ITRG 259.4K
- MRNS 5.7M
- Earning Date
- ITRG 11-12-2024
- MRNS 11-05-2024
- Dividend Yield
- ITRG N/A
- MRNS N/A
- EPS Growth
- ITRG N/A
- MRNS N/A
- EPS
- ITRG N/A
- MRNS N/A
- Revenue
- ITRG N/A
- MRNS $30,263,000.00
- Revenue This Year
- ITRG N/A
- MRNS $21.18
- Revenue Next Year
- ITRG $360.53
- MRNS $56.42
- P/E Ratio
- ITRG N/A
- MRNS N/A
- Revenue Growth
- ITRG N/A
- MRNS 16.56
- 52 Week Low
- ITRG $0.64
- MRNS $0.26
- 52 Week High
- ITRG $1.28
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- ITRG 66.49
- MRNS 21.75
- Support Level
- ITRG $0.95
- MRNS $0.29
- Resistance Level
- ITRG $1.28
- MRNS $1.96
- Average True Range (ATR)
- ITRG 0.07
- MRNS 0.12
- MACD
- ITRG 0.01
- MRNS -0.18
- Stochastic Oscillator
- ITRG 77.27
- MRNS 2.41
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.